Nombre | Último | Anterior | Máximo | Mínimo | % Var. | Vol. | Hora | Precio | |
---|---|---|---|---|---|---|---|---|---|
NOVOb Novo Nordisk A/S Class B | 928,80 | 937,40 | 940,70 | 922,80 | -0,92% | 1,88M | 928,80-0,92% | 24/05 | |
BIOPOR BioPorto | 1,75 | 1,76 | 1,77 | 1,692 | -0,57% | 503,67K | 1,75-0,57% | 24/05 | |
ZELA Zealand Pharma A/S | 586,50 | 603,00 | 589,00 | 560,00 | -2,74% | 482,11K | 586,50-2,74% | 24/05 | |
BAVA Bavarian Nordic | 180,00 | 177,60 | 180,00 | 174,10 | +1,32% | 433,21K | 180,00+1,32% | 24/05 | |
GMAB Genmab | 1.926,50 | 2.025,00 | 2.020,00 | 1.906,00 | -4,86% | 428,67K | 1.926,50-4,86% | 24/05 |
Nombre | Precio |
---|---|
PEGRP Pharma Equity AS | 0,261+0,008+3,16% |
BAVA Bavarian Nordic | 180,00+2,3+1,32% |
HLUNa H Lundbeck B | 32,400,000,00% |
NSISb Novozymes B | 424,10-0,9-0,21% |
ALKb ALK-Abello B | 154,30-0,70-0,45% |
Nombre | Precio |
---|---|
GMAB Genmab | 1.926,50-98,5-4,86% |
GUBRA Gubra AS | 311,00-9,00-2,81% |
ZELA Zealand Pharma | 586,50-16,50-2,74% |
ORPHA Orphazyme | 996,00-23,80-2,33% |
NOVOb Novo Nordisk B | 928,80-8,6-0,92% |